X0306 4 2019-09-20 0 0001087294 CUMBERLAND PHARMACEUTICALS INC CPIX 0001075050 KAZIMI A J 2525 WEST END AVE. SUITE 950 NASHVILLE TN 37203 1 1 1 0 Chairman and CEO Common Stock 2019-09-20 4 P 0 60 5.33 A 5766502 D Common Stock 2019-09-23 4 P 0 60 5.35 A 5766562 D Common Stock 2019-09-24 4 P 0 60 5.39 A 5766622 D Common Stock 2019-09-25 4 P 0 60 5.38 A 5766682 D Common Stock 2019-09-26 4 P 0 60 5.76 A 5766742 D Common Stock 2019-09-27 4 P 0 60 5.76 A 5766802 D Common Stock 2019-09-30 4 P 0 60 5.89 A 5766862 D Common Stock 2019-10-01 4 P 0 60 5.89 A 5766922 D Common Stock 2019-10-02 4 P 0 60 5.77 A 5766982 D Common Stock 2019-10-04 4 P 0 60 5.76 A 5767042 D Common Stock 2019-10-07 4 P 0 60 5.74 A 5767102 D Common Stock 2019-10-08 4 P 0 60 5.81 A 5767162 D Common Stock 2019-10-09 4 P 0 60 5.78 A 5767222 D Common Stock 2019-10-10 4 P 0 60 5.86 A 5767282 D Common Stock 2019-10-11 4 P 0 60 5.71 A 5767342 D Common Stock 2019-10-14 4 P 0 60 5.67 A 5767402 D Common Stock 2019-10-15 4 P 0 60 5.63 A 5767462 D Common Stock 2019-10-16 4 P 0 60 5.56 A 5767522 D Common Stock 2019-10-17 4 P 0 60 5.52 A 5767582 D Common Stock 2019-10-18 4 P 0 34 5.45 A 5767616 D The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2019. A.J. Kazimi by /s/ Michael Bonner as attorney-in-fact 2019-10-25